Wutah bathi EPS kuartalan iradimed.com (IRMD)

IRADIMED CORPORATION (IRMD) dominates the MRI-compatible pump segment, possessing exceptional pricing power over its devices. A proprietary high-tech manufacturing plant in the US with strict cleanroom controls guarantees supply stability. Narrow specialization is offset by global leadership, and the quarterly EPS growth reported on GURU.Markets highlights 16.50, which serves as the current benchmark for the business's fundamental stability.

The reliability of equity assets is determined by a business's ability to generate excess cash flow. This indicator measures the percentage change in earnings per share relative to the same quarter of the previous year. For IRADIMED CORPORATION (IRMD), high margins driven by the optimization of precision component supplies translate directly into growth for this metric. By analyzing quarterly earnings per share dynamics, an investor assesses the real momentum of the business. While the upward trend confirms the model's efficiency, it also signals the risk of overpaying for the asset.